Loading…

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis

Aims The study aimed to investigate the prevalence, phenotypic characteristics, and predictors of atrial fibrillation (AF) in patients presenting with cardiac amyloidosis (CA) of light‐chain (AL) or transthyretin (ATTR) type. Methods and results Clinical, biochemical, and echocardiographic data of p...

Full description

Saved in:
Bibliographic Details
Published in:ESC Heart Failure 2022-06, Vol.9 (3), p.1740-1748
Main Authors: Papathanasiou, Maria, Jakstaite, Aiste‐Monika, Oubari, Sara, Siebermair, Johannes, Wakili, Reza, Hoffmann, Julia, Carpinteiro, Alexander, Hagenacker, Tim, Thimm, Andreas, Rischpler, Christoph, Kessler, Lukas, Rassaf, Tienush, Luedike, Peter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims The study aimed to investigate the prevalence, phenotypic characteristics, and predictors of atrial fibrillation (AF) in patients presenting with cardiac amyloidosis (CA) of light‐chain (AL) or transthyretin (ATTR) type. Methods and results Clinical, biochemical, and echocardiographic data of patients presenting with CA between 2005 and 2020 were retrospectively collected. CA staging was based on established biomarker systems. Binomial logistic regression was run to analyse the effects of clinical variables on the likelihood of AF. The study included 133 patients [53% AL, 41% wild‐type (wt) ATTR‐CA, & 6% hereditary ATTR‐CA]. Mean age was 71 years, and 80% were male patients. AF was diagnosed in 64 (48%) patients (28% in AL‐CA, 80% in wtATTR, 13% in hATTR, P 
ISSN:2055-5822
2055-5822
DOI:10.1002/ehf2.13851